Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biochemistry ; 45(22): 6846-57, 2006 Jun 06.
Artigo em Inglês | MEDLINE | ID: mdl-16734421

RESUMO

Pulvomycin inhibits protein synthesis by preventing the formation of the ternary complex between elongation factor Tu (EF-Tu) x GTP and aa-tRNA. In this work, the crystal structure of Thermus thermophilus EF-Tu x pulvomycin in complex with the GTP analogue guanylyl imino diphosphate (GDPNP) at 1.4 A resolution reveals an antibiotic binding site extending from the domain 1-3 interface to domain 2, overlapping the domain 1-2-3 junction. Pulvomycin binding interferes with the binding of the 3'-aminoacyl group, the acceptor stem, and 5' end of tRNA. Only part of pulvomycin overlaps the binding site of GE2270 A, a domain 2-bound antibiotic of a structure unrelated to pulvomycin, which also hinders aa-tRNA binding. The structure of the T. thermophilus EF-Tu x GDPNP x GE2270 A complex at 1.6 A resolution shows that GE2270 A interferes with the binding of the 3'-aminoacyl group and part of the acceptor stem of aa-tRNA but not with the 5' end. Both compounds, pulvomycin more markedly, hinder the correct positioning of domain 1 over domains 2 and 3 that characterizes the active form of EF-Tu, while they affect the domain 1 switch regions that control the EF-Tu x GDP/GTP transitions in different ways. This work reveals how two antibiotics with different structures and binding modes can employ a similar mechanism of action.


Assuntos
Aminoglicosídeos/química , Antibacterianos/química , Fator Tu de Elongação de Peptídeos/química , Peptídeos Cíclicos/farmacologia , Aminoglicosídeos/farmacologia , Antibacterianos/farmacologia , Cristalografia , Fator Tu de Elongação de Peptídeos/efeitos dos fármacos , Peptídeos Cíclicos/química , Fenilalanina-tRNA Ligase/química , Conformação Proteica , Thermus thermophilus/efeitos dos fármacos , Thermus thermophilus/metabolismo , Tiazóis/química , Tiazóis/farmacologia
2.
Biochemistry ; 43(49): 15550-6, 2004 Dec 14.
Artigo em Inglês | MEDLINE | ID: mdl-15581367

RESUMO

The antibiotic pulvomycin is an inhibitor of protein synthesis that prevents the formation of the ternary complex between elongation factor (EF-) Tu.GTP and aminoacyl-tRNA. In this report, novel aspects of its action on EF-Tu are described. Pulvomycin markedly affects the equilibrium and kinetics of the EF-Tu-nucleotide interaction, particularly of the EF-Tu.GTP complex. The binding affinity of EF-Tu for GTP is increased 1000 times, mainly as the consequence of a dramatic decrease in the dissociation rate of this complex. In contrast, the affinity for GDP is decreased 10-fold due to a marked increase in the dissociation rate of EF-Tu.GDP (25-fold) that mimics the action of EF-Ts, the GDP/GTP exchange factor of EF-Tu. The effects of pulvomycin and EF-Ts can coexist and are simply additive, supporting the conclusion that these two ligands interact with different sites of EF-Tu. This is further confirmed on native PAGE by the ability of EF-Tu to bind the EF-Ts and the antibiotic simultaneously. Pulvomycin enhances the intrinsic EF-Tu GTPase activity, like kirromycin, though to a much more modest extent. As with kirromycin, this stimulation depends on the concentration and nature of the monovalent cations, Li(+) being the most effective one, followed by Na(+), K(+), and NH(4)(+). In the presence of pulvomycin (in contrast to kirromycin), aa-tRNA and/or ribosomes do not enhance the GTPase activity of EF-Tu. The property of pulvomycin to modify selectively the conformation(s) of EF-Tu is also supported by its effect on heat- and urea-dependent denaturation, and tryptic digestion of the protein. Specific differences and similarities between the action of pulvomycin and the other EF-Tu-specific antibiotics are described and discussed.


Assuntos
Aminoglicosídeos/química , Antibacterianos/química , Fator Tu de Elongação de Peptídeos/química , Fator Tu de Elongação de Peptídeos/metabolismo , Peptídeos Cíclicos/química , Aminoglicosídeos/metabolismo , Antibacterianos/metabolismo , Sítios de Ligação , Inibidores Enzimáticos/química , Estabilidade Enzimática , GTP Fosfo-Hidrolases/metabolismo , Guanosina Difosfato/metabolismo , Guanosina Trifosfato/metabolismo , Hidrólise , Fator Tu de Elongação de Peptídeos/antagonistas & inibidores , Fatores de Alongamento de Peptídeos/metabolismo , Peptídeos Cíclicos/metabolismo , Desnaturação Proteica , Piridonas/química , Piridonas/metabolismo , Tiazóis/química , Tiazóis/metabolismo , Tripsina/metabolismo , Ureia/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...